QuickView: Investing to accelerate long-term growth
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that has grown its revenues at an average annual rate of 20% over the past decade. AFT raised an estimated NZ$33m in its December 2015 public offering, which it will use to accelerate new product development and move into new geographies including the EU and US. The company trades at a still relatively modest 4.2x EV/sales based on TTM revenues to September 2015.AFT Pharmaceuticals is engaged in the distribution of pharmaceutical products and the development of pharmaceutical intellectual property.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.